• Markets
  • icon
  • Companies
CMP · ASX

Compumedics Limited (ASX:CMP)

AU$0.26

 0.025 (10.638%)
ASX:Live
23/05/2024 12:00:00 AM
HALO Ords GROWTH AUS Big Candle All-Companies
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

CMP Overview

CMP Health Scores

Short Term

Mean Revision

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Weak

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About CMP

Telephone

Address

Description

Compumedics Ltd. engages in the research, development, manufacture, and distribution of medical equipment and associated technologies. It offers innovative computer-based diagnostic technologies in the areas of sleep, neurology, and cardiology. The firm operates through the following geographical segments: Americas, Australia and Asia Pacific, and Europe and the Middle East. The Americas segment includes the United States, Canada, and Latin America. The Australia and Asia Pacific segment refers to all countries in the Asia Pacific region with major countries for the territory including Japan and China. The Europe and the Middle East segment focuses on all countries in the European region and all Middle Eastern countries. The company was founded by David Burton in 1987 and is headquartered in Abbotsford, Australia.

CMP Price Chart

Key Stats

Market Cap

AU$41.63M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.15 - 0.44

Trade Value (12mth)

AU$2,010.00

1 week

8.33%

1 month

0%

YTD

-7.14%

1 year

52.94%

All time high

0.9599999785423279

Key Fundamentals

EPS 3 yr Growth

4.800%

EBITDA Margin

-5.90%

Operating Cashflow

$0m

Free Cash Flow Return

0.20%

ROIC

-27.90%

Interest Coverage

-3.90

Quick Ratio

0.90

Other Data

Shares on Issue (Fully Dilluted)

177m

HALO Sector

Next Company Report Date

02-Sep-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

CMP Announcements

Latest Announcements

Date Announcements

23 May 24

FY24 Business Update

×

FY24 Business Update

29 February 24

Half Yearly Report and Accounts

×

Half Yearly Report and Accounts

29 February 24

Compumedics Leaps back to profits and growth

×

Compumedics Leaps back to profits and growth

11 January 24

Business Update December 31

×

Business Update December 31

12 December 23

$9.3m MEG sales to China

×

$9.3m MEG sales to China

11 December 23

Pause in Trading

×

Pause in Trading

11 December 23

Trading Halt

×

Trading Halt

04 December 23

Somfit FDA cleared for USA market

×

Somfit FDA cleared for USA market

01 December 23

Pause in Trading

×

Pause in Trading

01 December 23

Trading Halt

×

Trading Halt

16 November 23

Corporate Presentation Bell Potter Healthcare Conference 23

×

Corporate Presentation Bell Potter Healthcare Conference 23

31 October 23

Chair's Address to Shareholders

×

Chair's Address to Shareholders

31 October 23

Results of Meeting

×

Results of Meeting

04 October 23

Initial Director's Interest Notice

×

Initial Director's Interest Notice

02 October 23

Governance Statement

×

Governance Statement

02 October 23

Appendix 4G

×

Appendix 4G

28 September 23

Full Year Statutory Accounts

×

Full Year Statutory Accounts

28 September 23

Notice of General Meeting/Proxy Form

×

Notice of General Meeting/Proxy Form

30 August 23

Preliminary Final Report

×

Preliminary Final Report

30 August 23

Business Update June 2023

×

Business Update June 2023

06 July 23

Business Update - 30 June 2023

×

Business Update - 30 June 2023

06 July 23

Somfit Update - CPAP Direct

×

Somfit Update - CPAP Direct

03 July 23

Somfit Key Strategic Milestone Execution - Australia

×

Somfit Key Strategic Milestone Execution - Australia

04 May 23

Business Update

×

Business Update

06 April 23

Director Appointment/Resignation

×

Director Appointment/Resignation

08 March 23

Okti FDA Approval

×

Okti FDA Approval

CMP Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 0.01 0.01 -0.03 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 0.01 0.01 -0.03 Lock Lock Lock
     Growth % Lock Lock Lock Lock 117.0 37.5 -549.4 Lock Lock Lock
     PE X Lock Lock Lock Lock 53.9 N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 0.0 N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.01 0.02 -0.01 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock 0.01 0.02 -0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock 15.1 28.8 -156.8 Lock Lock Lock
     Yield % Lock Lock Lock Lock 1.7 9.7 -2.7 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock 0.0 N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.13 0.13 0.10 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.10 0.10 0.07 Lock Lock Lock
     Growth % Lock Lock Lock Lock -5.0 -5.2 -29.7 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 177 177 177 Lock Lock Lock
Basic m Lock Lock Lock Lock 177 177 177 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 36 38 42 Lock Lock Lock
     Growth % Lock Lock Lock Lock 1.9 5.6 12.3 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 19 19 25 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 19 19 22 Lock Lock Lock
     Growth % Lock Lock Lock Lock 6.4 0.8 11.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock 53.6 51.2 50.9 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 46 49 49 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 2 1 -3 Lock Lock Lock
     Growth % Lock Lock Lock Lock 104.3 -27.3 -286.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock 5.2 3.6 -5.9 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 1 1 1 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 0 0 -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock 152.6 -65.6 -2,679.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock 1.1 0.4 -8.3 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 1 2 -7 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 0 -1 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 1 1 -6 Lock Lock Lock
     Growth % Lock Lock Lock Lock 117.1 36.0 -551.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock 2.8 3.6 -14.4 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 1 3 0 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 2 3 4 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -2 -3 -4 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 0 2 -1 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 1 3 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock -76.7 130.1 -132.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.0 0.1 -0.0 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 7 7 4 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 39 42 41 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 1 0 2 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -1 -1 6 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 16 18 23 Lock Lock Lock
Equity $m Lock Lock Lock Lock 22 24 18 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 23 24 20 Lock Lock Lock
     Growth % Lock Lock Lock Lock 1.2 4.7 -17.2 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 2.6 3.3 -14.9 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 4.5 5.8 -33.5 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 1.5 0.5 -12.2 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 4.4 5.8 -27.9 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 5.8 14.0 0.2 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock 5.6 3.4 -3.9 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock -0.5 -0.6 -2.2 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -4.3 -3.2 31.0 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 2.1 1.9 1.4 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 1.4 1.4 0.9 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 21.2 21.7 12.9 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 8.6 18.7 0.2 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 2.5 2.4 2.7 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 1.8 1.9 2.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 2.2 2.4 5.1 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 12.4 12.5 12.4 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.9 0.9 1.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.9 0.9 1.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 2.2 4.5 -15.8 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 2.0 4.1 -16.3 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock -28.6 20.1 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 2.6 3.3 -14.9 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.7 1.8 2.3 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 4.5 5.8 -33.5 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 4.5 5.8 -33.5 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 203.8 191.9 178.8 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 148.7 154.8 135.9 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 352.5 346.7 314.7 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 77.2 90.8 83.7 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 275.3 255.9 231.0 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

CMP Shortsell

Frequently Asked Questions

The current share price of Compumedics Limited (CMP:ASX) is AU$0.26.
The 52-week high share price for Compumedics Limited (CMP:ASX) is AU$0.44.
The 52-week low share price for Compumedics Limited (CMP:ASX)? is AU$0.15.
Compumedics Limited (CMP:ASX) does not pay a dividend.
The last dividend payment of Compumedics Limited (CMP:ASX) is AU$0.01.
Compumedics Limited (CMP:ASX) has a franking level of 0.0%.
Compumedics Limited (CMP:ASX) is classified in the Healthcare.
The current P/E ratio for Compumedics Limited (CMP:ASX) is .